Toxicity Profiling and Antihyperuricemic Activity of Goubion: A Polyherbal Formulation.

Evid Based Complement Alternat Med · 2023 · PMC9946748 · PMID 36846052

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

No remarkable difference was observed in the mean LDL cholesterol values between control and different doses of Goubion, though an increasing trend with respect to the increase in dose was observed.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.